Bracco Gains FDA Clearance for VueJect Cardiac Imaging System
MILAN, Italy, August 11, 2026 Bracco Imaging has announced that its VueJect® ultrasound contrast delivery system has received 510(k)...
pharmaceutical acquisition
Advertisement
Alfasigma to Acquire Nordic Pharma in European M&A Deal
BOLOGNA AND MILAN, Italy, August 13, 2026 Alfasigma S.p.A. has entered into a share purchase agreement with SEVER Life...
Grifols Completes SPARTA Phase 3 Trial of Prolastin-C
Bridgewater, N.J., August 10, 2026 Grifols announced the completion of patient follow-up in SPARTA, its Phase 3 outcomes study...
Amneal Completes Kashiv BioSciences Acquisition to Expand Biosimilars
Bridgewater, N.J., August 10, 2026 Amneal Pharmaceuticals, Inc. has completed its acquisition of Kashiv BioSciences, LLC, creating a scaled,...
Lilly Acquires Engage Bio for Genetic Medicines
SAN CARLOS, Calif., May 22, 2026 Eli Lilly and Company has acquired Engage Bio, a preclinical biotechnology company focused...
Advertisements
AstraZeneca and Daiichi Sankyo Secure FDA Approval for Enhertu in Early HER2 Breast Cancer
WILMINGTON, Del., May 15, 2026 AstraZeneca and Daiichi Sankyo have announced that the U.S. Food and Drug Administration (FDA)...
SERB and Hansa Biopharma Strengthen Rare Disease Portfolio With Idefirix Agreement
BRUSSELS, Belgium, May 19, 2026 SERB Pharmaceuticals and Hansa Biopharma have announced a strategic €115 million licensing agreement granting...
Angelini Pharma to Acquire Catalyst Pharmaceuticals in $4.1 Billion Rare Disease Expansion Deal
ROME, Italy and CORAL GABLES, Florida, United States – May 7, 2026 Angelini Pharma S.p.A. and Catalyst Pharmaceuticals Inc....
Apotex Expands U.S. Portfolio via Cumberland Deal
TORONTO, April 23, 2026 Apotex Inc. and Cumberland Pharmaceuticals Inc. announced a strategic transaction to integrate Cumberland’s U.S. branded...
Lilly to Acquire Ventyx to Expand Oral Inflammation Therapies
INDIANAPOLIS | January 7, 2026 — Eli Lilly and Company has announced an agreement to acquire Ventyx Biosciences, a...
Advertisement
